EVALUATION OF A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, SPIRAPRIL, IN MILD TO MODERATE ESSENTIAL-HYPERTENSION

被引：0
|
作者：
WEBER, MA [1 ]
FERRARESI, RW [1 ]
POORVIN, D [1 ]
机构：
[1] SCHERING CORP, KENILWORTH, NJ USA
来源：
JOURNAL OF HYPERTENSION | 1986年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S171 / S173
页数：3
相关论文
共 50 条
  • [1] MODERATE SODIUM RESTRICTION WITH ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR IN ESSENTIAL-HYPERTENSION
    WALLER, PC
    MCINNES, GT
    BMJ-BRITISH MEDICAL JOURNAL, 1987, 294 (6574): : 769 - 769
  • [2] MULTICENTRIC STUDY OF QUINAPRIL, AN ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, IN THE TREATMENT OF MILD TO MODERATE ESSENTIAL-HYPERTENSION
    PARRACARRILLO, JZ
    ALCOCER, DBL
    OLVERA, S
    VERDEJO, J
    CAMPOS, E
    ASPE, J
    AGUIRRE, L
    HERNANDEZ, H
    BAHENA, JH
    SANCHEZ, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (02): : 185 - 195
  • [3] DOSE-RESPONSE RELATION OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR RAMIPRIL IN MILD TO MODERATE ESSENTIAL-HYPERTENSION
    WALTER, U
    FORTHOFER, R
    WITTE, PU
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10): : D125 - D132
  • [4] SYSTEMIC AND RENAL EFFECTS OF A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, BENAZEPRIL, IN ESSENTIAL-HYPERTENSION
    VALVO, E
    CASAGRANDE, P
    BEDOGNA, V
    ANTIGA, L
    ALBERTI, D
    ZAMBONI, M
    PEROBELLI, L
    DALSANTO, F
    MASCHIO, G
    JOURNAL OF HYPERTENSION, 1990, 8 (11) : 991 - 995
  • [5] COMBINED TREATMENT OF SEVERE ESSENTIAL-HYPERTENSION WITH THE NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR RAMIPRIL
    PREDEL, HG
    DUSING, R
    BACKER, A
    KIPNOWSKI, J
    KRAMER, HJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10): : D143 - D148
  • [6] MODERATE SODIUM RESTRICTION WITH ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND-STUDY
    MACGREGOR, GA
    MARKANDU, ND
    SINGER, DRJ
    CAPPUCCIO, FP
    SHORE, AC
    SAGNELLA, GA
    BMJ-BRITISH MEDICAL JOURNAL, 1987, 294 (6571): : 531 - 534
  • [7] THE EFFECTS OF BENAZEPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN MILD TO MODERATE ESSENTIAL-HYPERTENSION - A MULTICENTER STUDY
    MOSER, M
    ABRAHAM, PA
    BENNETT, WM
    BRACHFELD, N
    GOODMAN, RP
    MCKENNEY, JM
    HOLLIFIELD, JW
    KIRKENDALL, WM
    LASSETER, KC
    LEON, AS
    LUNN, JA
    MILLER, K
    MORGANROTH, J
    RUDDY, MC
    SAMBHI, MP
    STEIN, WJ
    WEBER, MA
    WILLIAMS, RL
    ZAWADA, ET
    DESILVA, J
    GOURLEY, LA
    WHALEN, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (03) : 322 - 329
  • [8] EFFICACY AND SAFETY OF CGS 16617, A NEW NONTHIOL ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
    DESILVA, JK
    HURLEY, ME
    WECLAWHAKIM, CM
    RIBEIRO, LGT
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (09): : 717 - 717
  • [9] THE ADDITION OF A CALCIUM-ANTAGONIST TO TREATMENT WITH AN ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    DONNELLY, R
    ELLIOTT, HL
    REID, JL
    CLINICAL SCIENCE, 1986, 71 : P46 - P46
  • [10] HUMORAL AND BLOOD-PRESSURE EFFECTS OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR RAMIPRIL IN ESSENTIAL-HYPERTENSION
    LENZ, T
    DISTLER, A
    HALLER, H
    MEYERSABELLEK, W
    WILP, C
    TANSEY, MJ
    ECKERT, HG
    METZGER, H
    IRMISCH, R
    PHILIPP, T
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1986, 36-2 (11): : 1693 - 1696
12345